Millipore Sigma Vibrant Logo
Atención: Nos hemos mudado. Los productos Merck Millipore ya no pueden adquirirse en MerckMillipore.comMás información
Home>Events>2nd European Viral Safety Experts Forum
In Molsheim, France
(Region of Strasbourg)

Join us and your peers for the 2nd European Viral Safety Experts Forum.

November 14-15, 2017 at the Merck office and M Lab™

Vibrant M Merck

The forum will bring together viral safety experts to exchange around viral safety strategies for biopharmaceuticals.

During this two-day forum, you will have the opportunity to share scientific knowledge, industry trends, and best practices towards the implementation of viral safety, looking for innovative solutions to today's evolving processing requirements.

We look forward to seeing you.

You are Invited

Register Now

Mercrobe EMD Millipore


Tuesday, November 14

9:00 - 09:45Breakfast and registration
 Process development and validation related topics
9:45 - 10:00Welcome and introduction
 Sarah Le Merdy, Technology Manager, Clarification, Viral Safety, Merck
10:00 - 11:00Virus risk mitigation in the development of biological medicinal products: a global regulatory perspective
 Martin Wisher, Senior Director, Global Head of Regulatory Affairs, Bioreliance
11:00 - 11:45Parvovirus-retentive filter performance and removal mechanisms during process interruptions
 David Bohonak, PhD, Senior Applications Engineer, Manufacturing Sciences and Technology, MilliporeSigma
11:45 - 12:30Screening and selection of prefiltration options prior to virus filtration
 Jérôme Pezzini, DSP Breakthrough Technologies Manager, Sanofi
12:30 - 13:30Poster session and lunch
13:30 - 14:15Differential retention of animal parvoviruses by virus filtration
 Dr. Thomas Nowak, Senior Manager in Virus Safety Development, Global Pathogen Safety of R&D, CSL Behring
14:15 - 14:45Nanofiltration optimisation using micro-titer plates
 Alison Tang, PhD, Downstream Development Scientist, MedImmune
14:45 - 15:30Overcoming filter fouling and virus breakthrough - Scale-down model qualification study
 Shohei Kobayashi, Supervisor of Downstream Development, API Process Development Department, Chugai Pharmaceutical Co., Ltd.
15:30 - 16:00Poster session and break
16:00 - 16:45Effect of product concentration on continuous parvovirus-retentive filtration
 David Bohonak, PhD, Senior Applications Engineer, Manufacturing Sciences and Technology, MilliporeSigma
16:45 - 17:30Best practices for supplier initiated changes to virus clearance validated steps: virus filtration and chromatography resins
 Michael O’Donohoe, PhD, Process & Technology Lead, Merck
Dawn MacNeill, Strategic Program Manager, Marketing Operations Filtration & Chromatography, MilliporeSigma
17:30 onwardsEvening event and networking dinner

Wednesday, November 15

8:30 - 10:00Step into an M Lab™ Collaboration Center
 Register to join us for a visit!
10:00 - 10:30Poster session and break
 Viral inactivation
10:30 - 11:15Viral inactivation step and impact of REACH regulation for LFB products: efforts to address substitution to Triton X-100
 Caroline Goussen, Viral & TSE Clearance Studies Manager, LFB Biotechnologies
11:15 - 12:30Paradigm shift in detergent virus inactivation: a novel detergent virus inactivation technology for biologics production
 Dr. Shengjiang Shawn Liu, Head and Principal Scientist, Pathogen Safety Department, Bayer
12:30 - 13:15Virus inactivation using chemicals: alternatives to Triton X-100
 Patricia Greenhalgh, Head of Virology Team, MilliporeSigma
13:15 - 14:00Poster session and lunch
 Upstream related topics
14:00 - 14:45Risk based upstream viral clearance approach at Biogen
 Aaron Mack, Engineer III, Materials Science, Biogen
14:45 - 15:45Defend your bioreactor: using nanofiltration to prevent virus contamination of cell culture processes
 Christina Carbrello, Senior Scientist in Filtration R&D, MilliporeSigma
15:45 - 16:00Closing remarks
 Sarah Le Merdy, Technology Manager, Clarification, Viral Safety, Merck

The life science business of Merck operates as MilliporeSigma in the U.S. and Canada.

Space is limited, register now!

*Agenda subject to change. Attendance to the "2nd European Viral Safety Experts Forum" is limited and available to pharma or biopharma manufacturers and academics only. The offer does not extend to any company that provides pharma or biopharma products or services. We reserve the right to revoke or refuse participation at any time. The meeting is free of charge. Dinner, lunches, and coffee breaks are provided compliments of Merck KGaA, Darmstadt, Germany. Hotel accommodations and travel costs are at the expense of the attendees. A block of rooms has been booked at different hotels close to the meeting venue.

M Lab™ Collaboration Center
M Lab™

Step into an M Lab™ Collaboration Center

Venue Information

Merck office and M Lab™
Millipore SAS
39 route industrielle de la Hardt
67120 Molsheim, France

We are Now One

Merck Millipore + Sigma-Aldrich =
the life science business of Merck

Operating in the U.S. and Canada
as MilliporeSigma